The continuum of care in hospitalized patients with opioid use disorder and infectious complications of drug use (choice)
Ended Awarded Last action
- Contract number
- 75N93022F00003
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,330,011
Award facts
- Contract value 100% obligated
- $2,330,011.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,330,011 |
About this award
This is a $2,330,011.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to PPD Development LP, a global contract research organization (CRO). The contract is for the "Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE)" and does not have a set-aside designation. PPD Development LP has been awarded over $500 million in prime federal contracts and participates as a subcontractor on grants and contracts worth over $100 million, covering a wide range of services centered on clinical trials and studies for vaccines, therapeutics, diagnostics, and medical countermeasures development. This contract is part of the company's work supporting NIH/NIAID's research initiatives, including under major indefinite delivery contract vehicles such as the Early Phase Clinical Trial Units IDC and the Comprehensive and Rapid Response contract.
Quick answers
Who was awarded contract 75N93022F00003?
75N93022F00003 was awarded to PPD Development LP by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 26, 2022.
How much is contract 75N93022F00003 worth?
The government has obligated $2,330,011 on 75N93022F00003.
Is contract 75N93022F00003 an order under another contract?
Yes. 75N93022F00003 is a delivery order under 75N93021D00035, an indefinite delivery contract.
Was contract 75N93022F00003 competed?
The extent of competition for 75N93022F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award